Dysbiosis of the gut microbiota in glioblastoma patients and potential biomarkers for risk assessment.

Haixiao JiangFang YangXiaoli ZhangHuie FangTao QiuYuping LiAijun Peng

Published in: Microbial pathogenesis (2024)

When compared to healthy people, glioblastoma sufferers have a different host-microbe interaction. Furthermore, certain types of intestinal flora could be regarded as biomarkers and drug targets for the diagnosis as well as treatment of glioblastomas.

Keyphrases

risk assessment
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
heavy metals
emergency department
patient reported outcomes
human health
adverse drug
electronic health record
smoking cessation